Accordingly, the current study set out to testify the aforementioned hypothesis and illuminate the underlying molecular mechanism of Rbpjl in pancreatic acinar cell and animal models of AP, in an effort to provide novel therapeutic strategies against AP. The gene discussed is RBPJL; the disease is alkaline phosphatase measurement.